Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
join our Department of Dermatology at the University of Maryland School of Medicine and provide patient care and education within our residency training program. The ideal candidate will have a strong
-
facilities programming, design, and construction services to the UMB schools and administration, ranging from the smallest renovation job to the largest capital project. BENEFITS (Exempt Regular): UMB offers a
-
(UMSOP) Department of Practice, Sciences, and Health Outcomes Research (P-SHOR) has an opening for an Administrative Assistant II for the Peer Review Program for Psychiatric Medications. This program is
-
with additional exciting perks that employees can take advantage of. This position participates in a retirement program (pension or optional retirement plan/ORP) that must be selected and is effective
-
Institute for Educators Teaching Certificate program and as needed in the departments of Organizational Systems and Adult Health (OSAH) and Family and Community Health (FCH). This position will be based
-
, Baltimore School of Pharmacy (UMSOP) Department of Practice, Sciences, and Health Outcomes Research (P-SHOR) has an opening for an Administrative Assistant II for the Peer Review Program for Psychiatric
-
wellness, work/life balance, and professional development, along with additional exciting perks that employees can take advantage of. This position participates in a retirement program (pension), effective
-
Coordinator or Specialist (Coordinator or Specialist, Community Program). Working with multiple organizations and state agencies, the Division of Addiction Research and Treatment serves as a leader in
-
Clinical Research Specialist for the Hematologic Malignancies research program. This position will be patient-facing and responsible for implementing clinical research protocols on behalf of the faculty
-
). Following an extensive training program, the Bone Marrow Research Specialist will be assigned a portfolio of cutting-edge Chimeric Antigen Receptor T-Cell Therapy (CAR-T) and other novel therapeutic trials